webinar register page

Long-Acting Injectable Cabotegravir for PrEP: Understanding Results of HPTN 083 & 084 and key areas for advocacy
Engage with researchers who led the studies about this injectable PrEP strategy and advocates who are leading essential advocacy efforts around the introduction of CAB-LA.

On the call, we’ll be joined by AVAC’s Emily Bass, Chiluyfa Kasanda from TALC in Zambia, Richard Lusimbo from Pan Africa ILGA, Sibongile Maseko who is an independent consultant and women’s health advocate based in Eswatini, and lead trial investigators Sinead Delany-Moretlwe from HPTN 084, and Raphael Landovitz from HPTN 083.

May 3, 2021 10:00 AM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: AVAC.